Bioorganic & Medicinal Chemistry 2009-04-15

Structural-activity relationship study of highly-functionalized imidazolines as potent inhibitors of nuclear transcription factor-kappaB mediated IL-6 production.

Daljinder K Kahlon, Theresa A Lansdell, Jason S Fisk, Jetze J Tepe

Index: Bioorg. Med. Chem. 17(8) , 3093-103, (2009)

Full Text: HTML

Abstract

We herein describe the synthesis and anti-inflammatory properties of a small library of imidazoline-based NF-kappaB inhibitors. The structure-activity relationship of various substituents on an imidazoline core structure was evaluated for the ability to inhibit NF-kappaB mediated IL-6 production. Optimization of the scaffolds was pursued by correlating luciferase-based NF-kappaB reporter assays with inhibition of IL-6 production in IL-1beta stimulated human blood. Several derivatives were found to inhibit NF-kappaB mediated IL-6 production in the nanomolar range in IL-1beta stimulated human blood.

Related Compounds

Structure Name/CAS No. Articles
β-Interleukin I (163-171), human Structure β-Interleukin I (163-171), human
CAS:106021-96-9